Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 5/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CRHBP | P24387 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.37 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2059655 | 0.83 | EPHX1 (0.36) | CA2HSD11B1GLAL3MBTL1EPHX1 | |
| SCHEMBL587576 | 0.81 | HSD11B1 (0.49) | HSD11B1L3MBTL1ALDH1A1TSHR | |
| Methacrylic Acid SCHEMBL11899769 | 0.78 | ALDH1A1 (0.44) | CA2HSD11B1GLAL3MBTL1EPHX1 | |
| SCHEMBL28891341 | 0.77 | HSD11B1 (0.41) | CA2HSD11B1GLAL3MBTL1EPHX1 | |
| SCHEMBL10323133 | 0.77 | GLA (0.41) | HSD11B1GLAL3MBTL1EPHX1ALDH1A1 | |
| SCHEMBL19757635 | 0.75 | HSD11B1 (0.47) | CA2HSD11B1GLAL3MBTL1EPHX1 | |
| SCHEMBL6451090 | 0.75 | ALDH1A1 (0.39) | CA2HSD11B1GLAL3MBTL1EPHX1 | |
| SCHEMBL159994 | 0.75 | HSD11B1 (0.47) | CA2HSD11B1GLAL3MBTL1EPHX1 | |
| Methacrylic Acid SCHEMBL11899770 | 0.75 | ALDH1A1 (0.38) | CA2HSD11B1GLAL3MBTL1EPHX1 | |
| SCHEMBL14917397 | 0.75 | TDP1 (0.46) | HSD11B1GLAL3MBTL1EPHX1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8785100-B2 | Two-component developer | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2014-07-22 | — | — | US | claimed |
| US-20130189612-A1 | TWO-COMPONENT DEVELOPER | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2013-07-25 | — | — | US | claimed |
| US-12037679-B2 | Method of forming a diamond film | APPLIED MATERIALS, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| US-20230279540-A1 | METHOD OF FORMING A DIAMOND FILM | APPLIED MATERIALS, INC. (US) | 2023-09-07 | — | — | US | disclosed |
| US-8785100-B2 | Two-component developer | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2014-07-22 | — | — | US | disclosed |
| US-20130189612-A1 | TWO-COMPONENT DEVELOPER | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2013-07-25 | — | — | US | disclosed |
| US-8389594-B2 | Silicone-modified adamantane derivative, photo-radically curable resin composition, and method for preparing photo-radically curable resin composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2013-03-05 | — | — | US | disclosed |
| US-20120136086-A1 | SILICONE-MODIFIED ADAMANTANE DERIVATIVE, PHOTO-RADICALLY CURABLE RESIN COMPOSITION, AND METHOD FOR PREPARING PHOTO-RADICALLY CURABLE RESIN COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120136086-A1 | SILICONE-MODIFIED ADAMANTANE DERIVATIVE, PHOTO-RADICALLY CURABLE RESIN COMPOSITION, AND METHOD FOR PREPARING PHOTO-RADICALLY CURABLE RESIN COMPOSITION | RAD51, PRMT1, ARGLU1 | CA2 4219/4885HSD11B1 3441/4885GLA 1159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.